695 related articles for article (PubMed ID: 18445624)
21. Genetic polymorphisms in the surfactant proteins in systemic sclerosis in Japanese: T/T genotype at 1580 C/T (Thr131Ile) in the SP-B gene reduces the risk of interstitial lung disease.
Sumita Y; Sugiura T; Kawaguchi Y; Baba S; Soejima M; Murakawa Y; Hara M; Kamatani N
Rheumatology (Oxford); 2008 Mar; 47(3):289-91. PubMed ID: 18263595
[TBL] [Abstract][Full Text] [Related]
22. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia.
Farre L; Bittencourt AL; Silva-Santos G; Almeida A; Silva AC; Decanine D; Soares GM; Alcantara LC; Van Dooren S; Galvão-Castro B; Vandamme AM; Van Weyenbergh J
J Leukoc Biol; 2008 Jan; 83(1):220-2. PubMed ID: 17962369
[TBL] [Abstract][Full Text] [Related]
23. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
Bossini-Castillo L; Simeon CP; Beretta L; Vonk MC; Callejas-Rubio JL; Espinosa G; Carreira P; Camps MT; Rodríguez-Rodríguez L; Rodríguez-Carballeira M; García-Hernández FJ; López-Longo FJ; Hernández-Hernández V; Sáez-Comet L; Egurbide MV; Hesselstrand R; Nordin A; Hoffmann-Vold AM; Vanthuyne M; Smith V; De Langhe E; Kreuter A; Riemekasten G; Witte T; Hunzelmann N; Voskuyl AE; Schuerwegh AJ; Lunardi C; Airó P; Scorza R; Shiels P; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Koeleman BP; Rueda B; Radstake TR; Martin J;
Rheumatology (Oxford); 2011 Nov; 50(11):1976-81. PubMed ID: 21875883
[TBL] [Abstract][Full Text] [Related]
24. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
[TBL] [Abstract][Full Text] [Related]
25. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis.
Sugiura Y; Banno S; Matsumoto Y; Niimi T; Yoshinouchi T; Hayami Y; Naniwa T; Ueda R
J Rheumatol; 2003 Jul; 30(7):1520-3. PubMed ID: 12858451
[TBL] [Abstract][Full Text] [Related]
27. A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels.
Mahfoudh W; Bel Hadj Jrad B; Romdhane A; Chouchane L
Int J Immunogenet; 2007 Jun; 34(3):209-12. PubMed ID: 17504511
[TBL] [Abstract][Full Text] [Related]
28. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.
Mattuzzi S; Barbi S; Carletto A; Ravagnani V; Moore PS; Bambara LM; Scarpa A
J Rheumatol; 2007 May; 34(5):997-1004. PubMed ID: 17444587
[TBL] [Abstract][Full Text] [Related]
29. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
Rueda B; Broen J; Torres O; Simeon C; Ortego-Centeno N; Schrijvenaars MM; Vonk MC; Fonollosa V; van den Hoogen FH; Coenen MJ; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Martin J; Radstake TR
Ann Rheum Dis; 2009 Feb; 68(2):253-6. PubMed ID: 18713787
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology.
Beretta L; Bertolotti F; Cappiello F; Barili M; Masciocchi M; Toussoun K; Caronni M; Scorza R
Hum Immunol; 2007 Jul; 68(7):603-9. PubMed ID: 17584583
[TBL] [Abstract][Full Text] [Related]
31. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
[TBL] [Abstract][Full Text] [Related]
32. Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis.
Carulli MT; Spagnolo P; Fonseca C; Welsh KI; duBois RM; Black CM; Denton CP
J Rheumatol; 2008 May; 35(5):839-44. PubMed ID: 18381789
[TBL] [Abstract][Full Text] [Related]
33. Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.
Kobak Ş; Berdeli A
Reumatismo; 2012 Dec; 64(6):374-9. PubMed ID: 23285481
[TBL] [Abstract][Full Text] [Related]
34. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
[TBL] [Abstract][Full Text] [Related]
35. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
[TBL] [Abstract][Full Text] [Related]
36. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
[TBL] [Abstract][Full Text] [Related]
37. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset.
Rak JM; Pagni PP; Tiev K; Allanore Y; Farge D; Harlé JR; Launay D; Hachulla E; Didelot R; Cabane J; Kahan A; Martin M; Granel B; Roudier J; Lambert NC
Rheumatology (Oxford); 2009 Apr; 48(4):363-6. PubMed ID: 19208687
[TBL] [Abstract][Full Text] [Related]
38. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
39. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population.
Almasi S; Erfani N; Mojtahedi Z; Rajaee A; Ghaderi A
Genes Immun; 2006 Jul; 7(5):401-6. PubMed ID: 16775619
[TBL] [Abstract][Full Text] [Related]
40. Association between Thr21Met and Ser89Asn polymorphisms of the urotensin II gene and systemic sclerosis.
Pehlivan Y; Gogebakan B; Oztuzcu S; Ozgen M; Cetin GY; Bayraktar R; Cengiz B; Kisacik B; Koca SS; Donmez S; Sayarlioglu M; Demiryurek AT; Onat AM
J Rheumatol; 2012 Jan; 39(1):106-11. PubMed ID: 22045841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
